Over the last 7 days, the Pharma industry has dropped 1.1%, driven by pullbacks in Merck and Eli Lilly of 3.1% and 1.2%, respectively. This takes the industry's 12 month performance to a gain of 18%. Earnings are forecast to grow by 27% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 05 Jul 2024 | US$1.9t | US$357.6b | US$13.8b | 15x | 140.4x | 5.4x |
Sun, 02 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.9x | 133.4x | 5.2x |
Tue, 30 Apr 2024 | US$1.8t | US$359.6b | US$17.5b | 23x | 102.8x | 5x |
Thu, 28 Mar 2024 | US$1.9t | US$355.3b | US$22.6b | 19.4x | 84.3x | 5.4x |
Sat, 24 Feb 2024 | US$1.9t | US$355.2b | US$24.0b | 24.1x | 80x | 5.4x |
Mon, 22 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 27.7x | 51.8x | 4.7x |
Wed, 20 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 26.9x | 49.4x | 4.5x |
Fri, 17 Nov 2023 | US$1.6t | US$375.4b | US$33.7b | 25.8x | 48.5x | 4.3x |
Sun, 15 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 18.3x | 38.9x | 4.5x |
Tue, 12 Sep 2023 | US$1.8t | US$381.8b | US$43.9b | 18x | 40x | 4.6x |
Thu, 10 Aug 2023 | US$1.8t | US$381.3b | US$44.5b | 19x | 40x | 4.7x |
Sat, 08 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 19x | 27.7x | 4.2x |
Mon, 05 Jun 2023 | US$1.7t | US$393.0b | US$60.5b | 18.9x | 28.3x | 4.4x |
Wed, 03 May 2023 | US$1.7t | US$392.8b | US$59.8b | 17.5x | 28.4x | 4.3x |
Fri, 31 Mar 2023 | US$1.6t | US$401.1b | US$69.5b | 15.7x | 22.5x | 3.9x |
Sun, 26 Feb 2023 | US$1.6t | US$401.8b | US$68.5b | 17.4x | 23.1x | 3.9x |
Tue, 24 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.9x | 23.9x | 4.2x |
Thu, 22 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.6x | 24.8x | 4.3x |
Sat, 19 Nov 2022 | US$1.7t | US$403.7b | US$70.6b | 14.2x | 24.4x | 4.3x |
Mon, 17 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 12.5x | 22.1x | 3.9x |
Wed, 14 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 13.7x | 22.6x | 4x |
Fri, 12 Aug 2022 | US$1.6t | US$402.9b | US$70.4b | 16.2x | 23.1x | 4x |
Sun, 10 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 21.9x | 26.2x | 4.3x |
Tue, 07 Jun 2022 | US$1.7t | US$392.5b | US$64.7b | 22x | 25.7x | 4.2x |
Thu, 05 May 2022 | US$1.6t | US$381.1b | US$60.0b | 21x | 27.2x | 4.3x |
Sat, 02 Apr 2022 | US$1.7t | US$373.8b | US$60.3b | 21.4x | 27.5x | 4.4x |
Mon, 28 Feb 2022 | US$1.5t | US$373.4b | US$59.4b | 21.3x | 25.9x | 4.1x |
Wed, 26 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 22.7x | 41.3x | 4.3x |
Fri, 24 Dec 2021 | US$1.7t | US$361.1b | US$37.9b | 22.6x | 43.7x | 4.6x |
Sun, 21 Nov 2021 | US$1.6t | US$360.7b | US$38.1b | 24x | 41.6x | 4.4x |
Tue, 19 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 21x | 59.9x | 4.4x |
Thu, 16 Sep 2021 | US$1.5t | US$338.7b | US$25.4b | 16.5x | 58.9x | 4.4x |
Sat, 14 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 22.1x | 62.1x | 4.7x |
61.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.09% | |
Healthcare | -1.72% | |
Pharma | -1.15% | |
Pharma | -1.15% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries | US$16.82 | 3.4% +US$634.3m | 114.8% | PS1.2x | |
LBPH Longboard Pharmaceuticals | US$31.91 | 54.5% +US$437.4m | 368.6% | PB4x | |
AXSM Axsome Therapeutics | US$80.21 | 4.0% +US$146.8m | 10.2% | PS15.2x | |
TARS Tarsus Pharmaceuticals | US$28.93 | 14.9% +US$142.1m | 67.7% | PS25.7x | |
WVE Wave Life Sciences | US$5.32 | 21.6% +US$115.7m | 39.6% | PS5.8x |